Adaptive Biotechnologies
ADPT
#4738
Rank
โ‚น180.21 B
Marketcap
โ‚น1,170
Share price
-11.10%
Change (1 day)
66.15%
Change (1 year)

Market capitalization of Adaptive Biotechnologies (ADPT)

Market cap: โ‚น180.21 Billion

As of March 2026 Adaptive Biotechnologies has a market cap of โ‚น180.21 Billion. This makes Adaptive Biotechnologies the world's 4738th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptive Biotechnologies from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น180.21 B-21.26%
2025โ‚น228.86 B187.4%
2024โ‚น79.63 B34.84%
2023โ‚น59.05 B-34.68%
2022โ‚น90.41 B-69.33%
2021โ‚น294.75 B-50.16%
2020โ‚น591.46 B121.35%
2019โ‚น267.21 B

End of Day market cap according to different sources

On Mar 27th, 2026 the market cap of Adaptive Biotechnologies was reported to be:

โ‚น180.21 Billion
by Nasdaq info icon info icon
โ‚น180.21 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HCA Healthcare
HCA
โ‚น9.951 T 5,421.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
โ‚น220.36 B 22.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Community Health Systems
CYH
โ‚น37.39 B-79.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Select Medical Holdings
SEM
โ‚น190.52 B 5.72%๐Ÿ‡บ๐Ÿ‡ธ USA